Cite Filings / CADL / 0001193125-23-044239

Feed Companies Filings Check

Sign in

8-K

Current Report

Candel Therapeutics, Inc. Filed 2023-02-22 Acc 0001193125-23-044239

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , d470958d8k.htm

Around this filing

2023-03-30 8-K Results of operations
2023-02-22 8-K Regulation FD disclosure
2023-02-17 4/A Director bought 27,000 shares at an average $1.89 ($51,108)
2022-12-06 8-K Regulation FD disclosure

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading d470958d8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…